Cargando…

Evaluating State-Level Prescription Drug Monitoring Program (PDMP) and Pill Mill Effects on Opioid Consumption in Pharmaceutical Supply Chain

The opioid crisis in the United States has had devastating effects on communities across the country, leading many states to pass legislation that limits the prescription of opioid medications in an effort to reduce the number of overdose deaths. This study evaluates the impact of two categories of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahebi-Fakhrabad, Amirreza, Sadeghi, Amir Hossein, Handfield, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914561/ https://www.ncbi.nlm.nih.gov/pubmed/36767012 http://dx.doi.org/10.3390/healthcare11030437

Ejemplares similares

The Impact of Opioid Prescribing Limits on Drug Usage in South Carolina: A Novel Geospatial and Time Series Data Analysis
por: Sahebi-Fakhrabad, Amirreza, et al.
Publicado: (2023)

Heroin Overdose Hospitalization Risk due to Prescription Opioids using PDMP in WI.
por: Raol, Gayatri, et al.
Publicado: (2018)

The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016–2020
por: Adalbert, Jenna R., et al.
Publicado: (2023)

Biopharmaceutical Supply Chains
por: Handfield, Robert
Publicado: (2012)

Unsolicited reporting notifications (URNs) through Maryland's prescription drug monitoring program (PDMP): Characteristics of providers
por: Amin-Esmaeili, Masoumeh, et al.
Publicado: (2022)

Pharmaceutical Supply Chain
por: Kuglin, Fred
Publicado: (2015)

PDMP induces rapid changes in vacuole morphology in Arabidopsis root cells
por: Krüger, Falco, et al.
Publicado: (2013)

Information flow in the pharmaceutical supply chain
por: Yousefi, Nazila, et al.
Publicado: (2015)

The Glucosylceramide Synthase Inhibitor PDMP Causes Lysosomal Lipid Accumulation and mTOR Inactivation
por: Hartwig, Pia, et al.
Publicado: (2021)

The geography of prescription pharmaceuticals supplied to the USA: levels, trends, and implications
por: Shivdasani, Yashna, et al.
Publicado: (2021)

Blurry vision: Supply chain visibility for personal protective equipment during COVID-19()
por: Finkenstadt, Daniel Joseph, et al.
Publicado: (2021)

Pharmaceutical supply chain risks: a systematic review
por: Jaberidoost, Mona, et al.
Publicado: (2013)

Implementation of the circular supply chain management in the pharmaceutical industry
por: Khan, Feroz, et al.
Publicado: (2022)

The Association of Prescriber Awareness of Opioid Consumption Trends with Postoperative Opioid Prescription Volume in Hip Arthroscopy: Prescriber Awareness of Opioid Consumption
por: Cunningham, Daniel J., et al.
Publicado: (2020)

Association of Acute Hyperglycemia and Diabetes Mellitus with Platelet-derived Microparticle (PDMP) Levels During Acute Myocardial Infarction
por: Indana, Hana Anindya, et al.
Publicado: (2023)

Standardized Opioid Prescription Protocol Reduces Opioid Consumption After Total Joint Arthroplasty
por: Vaz, Kenneth M., et al.
Publicado: (2019)

Demand amplification in supply chains of mills close to and far from main markets
por: Hameri, A P, et al.
Publicado: (1999)

A novel approach for inventory problem in the pharmaceutical supply chain
por: Candan, Gökçe, et al.
Publicado: (2016)

Do companies in the pharmaceutical supply chain earn excess returns?
por: Sood, Neeraj, et al.
Publicado: (2021)

Pill Peddlers: essays on the history of the pharmaceutical industry
por: Weatherall, M.
Publicado: (1991)

Designing a Transportation-Strategy Decision-Making Process for a Supply Chain: Case of a Pharmaceutical Supply Chain
por: Haial, Afaf, et al.
Publicado: (2021)

COVID-19 disruptions and Norwegian food and pharmaceutical supply chains: Insights into supply chain risk management, resilience, and reliability
por: Bø, Eirill, et al.
Publicado: (2023)

Developing a Model for Agile Supply: an Empirical Study from Iranian Pharmaceutical Supply Chain
por: Rajabzadeh Ghatari, Ali, et al.
Publicado: (2013)

Drug and medical device product failures and the stability of the pharmaceutical supply chain
por: Livingston, Alex N., et al.
Publicado: (2021)

Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic
por: BenAmor, W. Daoud, et al.
Publicado: (2022)

Identification of key drivers for improving inventory management in pharmaceutical supply chains
por: Hansen, Zaza Nadja Lee, et al.
Publicado: (2023)

Opioid Prescription Consumption Patterns After Total Joint Arthroplasty in Chronic Opioid Users Versus Opioid Naive Patients
por: Kaidi, Austin C., et al.
Publicado: (2020)

Is the number of prescriptions an appropriate metric for outpatient antimicrobial consumption? A comparison between the prescription counts and days supplied
por: Kakiuchi, Satoshi, et al.
Publicado: (2023)

Distributor– Retailer Interface in Pharmaceutical Supply Chain: Service Quality Measurement Scale
por: Mehralian, Gholamhossein, et al.
Publicado: (2016)

The Impact of Brexit on the Pharmaceutical Supply Chain of the United Kingdom: Scoping Review Protocol
por: Milne-Ives, Madison, et al.
Publicado: (2020)

The U.S. medicine chest: Understanding the U.S. pharmaceutical supply chain and the role of the pharmacist
por: Costantino, Ryan C.
Publicado: (2021)

Drugs quality supervision strategy of different distribution channels in pharmaceutical supply chain
por: Zhang, Siyi, et al.
Publicado: (2022)

Benchmarking the Quality Practices of Global Pharmaceutical Manufacturing to Advance Supply Chain Resilience
por: Fellows, Matt, et al.
Publicado: (2022)

Ensuring Trust in Pharmaceutical Supply Chains by Data Protection by Design Approach to Blockchains
por: Kayhan, Halid
Publicado: (2022)

How did you know you got the right pill? Prescription opioid identification and measurement error in the abuse deterrent formulation era
por: Green, Traci C, et al.
Publicado: (2015)

A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 vaccine supply chain()
por: Gilani, Hani, et al.
Publicado: (2022)

Cost-benefit analysis of the integrated pharmaceutical supply chain information service after the establishment of the Korean Pharmaceutical Information Service
por: Kim, Myojeong, et al.
Publicado: (2022)

Retailer Stackelberg game in a supply chain with pricing and service decisions and simple price discount contract
por: Sadjadi, Seyed Jafar, et al.
Publicado: (2018)

Developing a Suitable Model for Supplier Selection Based on Supply Chain Risks: An Empirical Study from Iranian Pharmaceutical Companies
por: Mehralian, Gholamhossein, et al.
Publicado: (2012)

A call to look beyond prescription opioid supply-side restrictions and include health equity when predicting opioid policy effectiveness
por: Goodin, Amie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q9gnt571m83hol1k18s7lfqn51